BACKGROUND: Clinical trials demonstrating that angiotensin-converting enzyme (ACE)
inhibitors reduce mortality when prescribed following myocardial infarction have focused on …

This review summarizes the evidence from five of the larger randomized controlled trials
evaluating the effects of angiotensin converting enzyme inhibitors started in the early phase …

Angiotensin-converting enzyme (ACE) inhibitors are now established drugs in the treatment
of hypertension and heart failure. However, their use in patients after a myocardial infarction …

OBJECTIVES Estimate the effect of angiotensin converting enzyme (ACE) inhibitors on the
risk of sudden cardiac death (SCD) following myocardial infarction (MI). BACKGROUND …

A number of major studies have examined the impact of angiotensin-converting enzyme
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …

BACKGROUND: Although angiotensin-converting enzyme (ACE) inhibitors have appeared
to be useful for secondary prevention after acute myocardial infarction (AMI) in Western …

Angiotensin-converting enzyme (ACE) inhibitor therapy has been associated with a
substantial (≥ 20%) reduction in the risk of major ischemic events in two recent clinical trials …

Controversy exists regarding whether all patients with acute myocardial infarction (AMI)
benefit from angiotensin-converting enzyme inhibitors (ACEIs). We examined the …

Few studies have investigated whether angiotensin II receptor blocker (ARB) is a practical
alternative to angiotensin-converting enzyme inhibitor (ACEI) for long-term use after acute …

What is already known about this subject• Treatment with an angiotensin‐converting
enzyme (ACE) inhibitor benefits many patients with cardiovascular disease.• ACE inhibitors …